106434-14-4CC[C@H](C)[C@H]1O[C@]2(C=C[C@@H]1C)C[C@@H]1C[C@@H](C/C=C(\C)[C@@H](O[C@H]3C[C@H](OC)[C@@H](O[C@H]4C[C@H](OC)[C@@H](O)[C@H](C)O4)[C@H](C)O3)[C@@H](C)/C=C/C=C3\CO[C@@H]4[C@H](O)C(C)=C[C@H](C(=O)O1)[C@]34O)O2RRZXIRBKKLTSOM-TYECJXEWSA-N106434-14-4용도epi-Avermectin B1a is a base-catalysed intermediate in the decomposition of avermectin B1a. epi-Avermectin B1a is formed by epimerisation at the 2-position which ultimately rearranges irreversibly to the isomeric alkene analogue, Δ2-avermectin B1a. epi-Avermectin B1a is only very weakly active as a nematocide showing ~100-fold loss of biological activity compared with the parent avermectin. epi-Avermectin B1a is formed in vivo following treatment with avermectin and is an environmental degradation product.
현재 필터 조건에 해당하는 반응 기록이 없습니다.
불러오는 중…